Abstract
Autoimmune diseases such as the diabetes that develops in NOD mice depend on immunologic recognition of specific autoantigens, but recognition can result in a pathogenic or protective T cell response. A study by Du et al. in this issue of the JCI demonstrates that TGF-β signaling by T cells recognizing the insulin peptide B:9-23 is essential for such protection and that this inhibitory cytokine functions in both a paracrine and an autocrine manner (see the related article beginning on page 1360). We propose that the insulin peptide B:9-23 and a conserved TCR motif form an "immunologic homunculus" underlying the relatively common targeting of insulin by T cells that, as demonstrated by the study of Du and coworkers, results in a protective T cell response, or diabetes, as shown by other investigators, for related T cell receptors.
| Original language | English |
|---|---|
| Pages (from-to) | 1212-1215 |
| Number of pages | 4 |
| Journal | Journal of Clinical Investigation |
| Volume | 116 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1 May 2006 |
| Externally published | Yes |